CELON PHARMA share#snapshot#suffix 33940801 / PLCLNPH00015
4.46
EUR
-0.01
EUR
-0.11
%
22:44:28
BMN
| prices + charts + realtime | news + analysis | fundamental | company | corresponding shares | action | |
|---|---|---|---|---|---|---|
| price + Chart | chart (large) | news + ad-hoc | balance sheet/p&l | fixed dates | certificates | portfolio#add_instrument_to#depot |
| times + sale | chart comparison | analysis | detailnavigation#shares#estimates | profile | portfolio#add_instrument_to#watchlist | |
| stock exchange | realtime push | stock price appreciation potential | dividend/annual shareholders' meeting | |||
| historic | analysis | |||||
prices + charts + realtime
news + analysis
fundamental
company
corresponding shares
CELON PHARMA Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2025 | CELON PHARMA S.A. | 0.00 | 0.00 | PLN |
| 2024 | CELON PHARMA S.A. | 0.00 | 0.00 | PLN |
| 2023 | CELON PHARMA S.A. | 0.52 | 0.08 | PLN |
| 2022 | CELON PHARMA S.A. | 0.57 | 0.08 | PLN |
| 2021 | CELON PHARMA S.A. | 0.87 | 0.29 | PLN |
| 2020 | CELON PHARMA S.A. | 0.17 | 0.07 | PLN |
| 2019 | CELON PHARMA S.A. | 0.20 | 0.08 | PLN |
| 2018 | CELON PHARMA S.A. | 0.77 | 0.24 | PLN |
| 2017 | CELON PHARMA S.A. | 0.47 | 0.17 | PLN |
| 2016 | CELON PHARMA S.A. | 0.69 | 0.17 | PLN |
share#balance#profitpershare- CELON PHARMA
| -1.5 25 | -0.6 24 | -0.6 23 | -0.8 22 | -0.2 21 | 0.5 20 | 0.3 19 |
share#balance#salespershare- CELON PHARMA
| 3.9 25 | 3.4 24 | 3.3 23 | 3.2 22 | 3.7 21 | 3.1 20 | 2.3 19 |
share#balance#p_e_ratio- CELON PHARMA
| 84.9 20 | 150 19 |
CELON PHARMA S.A.: share#balance#headline#theshare (in PLN)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (berichtet) | -1.49 | -0.64 | -0.55 | -0.77 | -0.25 | 0.48 | 0.27 |
| Gewinn je Aktie (unverwässert) | -1.49 | -0.66 | -0.55 | -0.77 | -0.25 | 0.48 | 0.27 |
| Gewinn je Aktie (verwässert) | -1.49 | -0.66 | -0.55 | -0.77 | -0.25 | 0.48 | 0.27 |
| Dividende je Aktie | 0.00 | 0.00 | 0.08 | 0.08 | 0.29 | 0.07 | 0.08 |
| Veränderung Dividende je Aktie in % | - | -100.00 | 0.00 | -72.41 | 314.29 | -12.50 | -66.67 |
| share#balance#cell#dividend_payment | 0.00 | 4.09 | 4.60 | 14.80 | 3.15 | 3.60 | 7.20 |
CELON PHARMA S.A.: share#balance#business_ratio (in PLN)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales_share | 3.95 | 3.42 | 3.27 | 3.19 | 3.70 | 3.09 | 2.27 |
| KGV (Jahresendkurs, Gewinn unverwässert) | - | - | - | - | - | 84.89 | 149.70 |
| KGV (Jahresendkurs, Gewinn verwässert) | - | - | - | - | - | 84.89 | 149.70 |
| share#balance#cell#dividend_ratio | 0.00 | 0.00 | 0.52 | 0.57 | 0.87 | 0.17 | 0.20 |
| share#balance#cell#equity_ratio | 79.40 | 81.87 | 78.26 | 74.62 | 78.34 | 61.77 | 75.26 |
| share#balance#cell#debt_ratio | 20.60 | 18.13 | 21.74 | 25.38 | 21.66 | 38.23 | 24.74 |
CELON PHARMA S.A.: share#balance#headline#income_statement (in Mio. PLN)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales | 209.80 | 179.75 | 167.04 | 162.62 | 172.58 | 139.27 | 102.25 |
| share#balance#cell#sales_change | 16.71 | 7.61 | 2.72 | -5.77 | 23.92 | 36.21 | -18.36 |
| share#balance#cell#sales_gross_profit | -39.48 | -55.31 | -60.92 | -55.64 | -20.59 | 85.19 | 64.26 |
| share#balance#cell#sales_gross_profit_change | 28.63 | 9.20 | -9.49 | -170.22 | - | 32.56 | -23.05 |
| share#balance#cell#operating_income | -56.76 | -79.65 | -76.82 | -69.76 | -35.16 | 23.85 | 1.90 |
| share#balance#cell#operating_income_change | 28.73 | -3.67 | -10.12 | -98.42 | - | 1’155.00 | -93.96 |
| share#balance#cell#income_before_tax | -24.86 | -33.82 | -19.97 | -36.45 | -15.09 | 22.07 | 7.81 |
| share#balance#cell#income_before_tax_change | 26.51 | -69.39 | 45.21 | -141.57 | - | 182.61 | -79.17 |
| share#balance#cell#income_after_tax | -79.36 | -34.45 | -28.12 | -39.28 | -11.61 | 21.50 | 11.94 |
| share#balance#cell#income_after_tax_change | -130.39 | -22.48 | 28.40 | -238.39 | - | 80.10 | -59.81 |
CELON PHARMA S.A.: share#balance#headline#balance (in Mio. PLN)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fremdkapital | 94 | 99 | 124 | 163 | 153 | 269 | 146 |
| Langzeit Gesamtverbindlichk. je Aktie | 0.21 | 0.21 | 0.28 | 0.41 | 0.72 | 1.07 | 0.26 |
| share#balance#cell#total_equity | 363 | 445 | 446 | 480 | 554 | 435 | 445 |
| share#balance#cell#total_equity_change | -18.41 | -0.08 | -7.11 | -13.42 | 27.45 | -2.33 | -0.82 |
| share#balance#cell#total_liabilities_and_equity | 457 | 544 | 569 | 643 | 707 | 704 | 591 |
| share#balance#cell#total_liabilities_and_equity_change | -15.88 | -4.48 | -11.43 | -9.10 | 0.50 | 18.99 | 4.91 |
CELON PHARMA S.A.: share#balance#headline#other_data (in PLN)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | -1.49 | -0.66 | -0.55 | -0.77 | -0.25 | 0.48 | 0.27 |
| Veränderung Gewinn je Aktie (unverwässert) in % | -127.70 | -19.10 | 28.45 | -209.53 | -152.06 | 80.13 | -59.81 |
| Gewinn je Aktie (verwässert) | -1.49 | -0.66 | -0.55 | -0.77 | -0.25 | 0.48 | 0.27 |
| Veränderung Gewinn je Aktie (verwässert) in % | -127.70 | -19.10 | 28.45 | -209.53 | -152.06 | 80.13 | -59.81 |
| share#balance#cell#employees | 562 | 558 | 515 | 523 | 488 | 467 | 440 |
| share#balance#cell#employees_change | 0.72 | 8.35 | -1.53 | 7.17 | 4.50 | 6.14 | - |
CELON PHARMA S.A. Termine
| Unternehmen | Event | Datum |
|---|---|---|
| CELON PHARMA S.A. | Quartalszahlen | 18.11.2026 |
| CELON PHARMA S.A. | Quartalszahlen | 28.04.2027 |
| CELON PHARMA S.A. | Quartalszahlen | 26.05.2027 |
| CELON PHARMA S.A. | Quartalszahlen | 22.09.2027 |
| CELON PHARMA S.A. | Quartalszahlen | 24.11.2027 |
CELON PHARMA S.A. vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q2 2026 Earnings Release | 16.09.2026 |
| Quartalszahlen | Q1 2026 Earnings Release | 20.05.2026 |
| Quartalszahlen | Q4 2025 Earnings Release | 22.04.2026 |
| Quartalszahlen | Q3 2025 Earnings Release | 19.11.2025 |
| Quartalszahlen | Q2 2025 Earnings Release | 17.09.2025 |
| Quartalszahlen | Q1 2025 Earnings Release | 21.05.2025 |
| Quartalszahlen | Q4 2024 Earnings Release | 16.04.2025 |
| Quartalszahlen | Q3 2024 Earnings Release | 20.11.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 18.09.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 22.05.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 24.04.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 22.11.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 20.09.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 24.05.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 19.04.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 23.11.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 28.09.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 25.05.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 27.04.2022 |
| Quartalszahlen | Q3 2021 Earnings Release | 29.11.2021 |
share#companyprofile#balance#staff#headline
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#employees | 440 | 467 | 488 | 523 | 515 |
| share#companyprofile#balance#staff#salesperemployee | 0.23 | 0.30 | 0.35 | 0.31 | 0.32 |
Bilanz (in Mio. PLN) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#currentassets | 144 | 119 | 279 | 238 | 190 |
| share#companyprofile#balance#staff#fixedassets | 448 | 585 | 428 | 405 | 380 |
| share#companyprofile#balance#staff#totalassets | 591 | 704 | 707 | 643 | 569 |
Bilanz (in Mio. PLN) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#totalborrowing | 146 | 269 | 153 | 163 | 124 |
| share#companyprofile#balance#staff#totalequity | 445 | 435 | 554 | 480 | 446 |
| share#companyprofile#balance#staff#totalliabilities | 591 | 704 | 707 | 643 | 569 |